Matosevic Lab
@matoseviclab.bsky.social
Cancer immunotherapy lab at Purdue University. Natural killer cells, CAR-NK, immunology, innate immunity, tumor microenvironment, solid tumors. matoseviclab.com
Enjoyed visiting Rush University’s Department of Microbial Pathogens and Immunity in Chicago; met amazing students and spoke to faculty who do incredible work. And if you enjoy long walks, here’s a photo of a super long and wide hallway in the Cook County Hospital, now a hotel, on the Rush campus.
May 22, 2025 at 5:10 AM
Enjoyed visiting Rush University’s Department of Microbial Pathogens and Immunity in Chicago; met amazing students and spoke to faculty who do incredible work. And if you enjoy long walks, here’s a photo of a super long and wide hallway in the Cook County Hospital, now a hotel, on the Rush campus.
Excited to share our latest article where we review patient studies (and some preclinical data) to uncover the breadth of NK cell diversity (and some dysfunction) in various cancers — great work Rishabh! link.springer.com/article/10.1...
The diversity of natural killer cell functional and phenotypic states in cancer - Cancer and Metastasis Reviews
The role of natural killer (NK) cells as immune effectors is well established, as is their utility as immunotherapeutic agents against various cancers. However, NK cells’ anti-cancer roles are suppres...
link.springer.com
January 24, 2025 at 2:21 PM
Excited to share our latest article where we review patient studies (and some preclinical data) to uncover the breadth of NK cell diversity (and some dysfunction) in various cancers — great work Rishabh! link.springer.com/article/10.1...
Reposted by Matosevic Lab
💪 Persistence makes progress.
Here's to 2025. 🎇
#Purdue #Cancer #Science #NewYear #HappyNewYear #HappyNYE #Happy2025 #Research #NewYearsEve #celebrate #NewYear2025 #Indiana #College
Here's to 2025. 🎇
#Purdue #Cancer #Science #NewYear #HappyNewYear #HappyNYE #Happy2025 #Research #NewYearsEve #celebrate #NewYear2025 #Indiana #College
December 31, 2024 at 6:06 PM
💪 Persistence makes progress.
Here's to 2025. 🎇
#Purdue #Cancer #Science #NewYear #HappyNewYear #HappyNYE #Happy2025 #Research #NewYearsEve #celebrate #NewYear2025 #Indiana #College
Here's to 2025. 🎇
#Purdue #Cancer #Science #NewYear #HappyNewYear #HappyNYE #Happy2025 #Research #NewYearsEve #celebrate #NewYear2025 #Indiana #College
Incredible undergraduate student Khanh presented her first research poster at the Purdue Undergraduate Research Expo. The first of many I’m sure. It was a success! Very proud of her. #nkcells #immunotherapy
November 27, 2024 at 12:13 PM
Incredible undergraduate student Khanh presented her first research poster at the Purdue Undergraduate Research Expo. The first of many I’m sure. It was a success! Very proud of her. #nkcells #immunotherapy
Reposted by Matosevic Lab
Listen up 👂
It's hard to over-hype this paper from Michelle Monje and Crystal Mackall on cellular therapy for #DIPG, a fatal childhood brain cancer.
It's not a perfect therapy; doesn't always work. By goodness, what progress we are making!
#CanSky
#MEDsky
#PedCanSky
www.nature.com/articles/s41...
It's hard to over-hype this paper from Michelle Monje and Crystal Mackall on cellular therapy for #DIPG, a fatal childhood brain cancer.
It's not a perfect therapy; doesn't always work. By goodness, what progress we are making!
#CanSky
#MEDsky
#PedCanSky
www.nature.com/articles/s41...
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas - Nature
We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M+ diffuse midline glioma (DMG), finding that intravenous administration of GD2-CART, followed by i...
www.nature.com
November 14, 2024 at 2:04 AM
Listen up 👂
It's hard to over-hype this paper from Michelle Monje and Crystal Mackall on cellular therapy for #DIPG, a fatal childhood brain cancer.
It's not a perfect therapy; doesn't always work. By goodness, what progress we are making!
#CanSky
#MEDsky
#PedCanSky
www.nature.com/articles/s41...
It's hard to over-hype this paper from Michelle Monje and Crystal Mackall on cellular therapy for #DIPG, a fatal childhood brain cancer.
It's not a perfect therapy; doesn't always work. By goodness, what progress we are making!
#CanSky
#MEDsky
#PedCanSky
www.nature.com/articles/s41...
Reposted by Matosevic Lab
Beyond the blood: expanding CAR T cell therapy to solid tumors. #CART #CellTherapy #NatureBiotechnology
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Beyond the blood: expanding CAR T cell therapy to solid tumors - Nature Biotechnology
Recent clinical trials testing CAR T cells on solid tumors have yielded promising outcomes that can be enhanced with further CAR engineering.
www.nature.com
November 12, 2024 at 11:06 PM
Beyond the blood: expanding CAR T cell therapy to solid tumors. #CART #CellTherapy #NatureBiotechnology
www.nature.com/articles/s41...
www.nature.com/articles/s41...
